(Q36938854)

17 August 2017

Intravenous calcitriol therapy in an early stage prevents parathyroid gland growth (English)

1 reference

17 August 2017

Masatomo Taniguchi

1

1 reference

17 August 2017

Masanori Tokumoto

2

1 reference

17 August 2017

Kazuhiko Tsuruya

3

1 reference

17 August 2017

Hideki Hirakata

4

1 reference

17 August 2017

Mitsuo Iida

5

1 reference

17 August 2017

language of work or name

English

0 references

publication date

30 May 2008

1 reference

Nephrology Dialysis Transplantation

17 August 2017

1 reference

17 August 2017

23

1 reference

17 August 2017

11

1 reference

17 August 2017

3662-3669

1 reference

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568009

Molecular genetics of hyperparathyroid disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568009

Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568009

Rat calcium-sensing receptor is regulated by vitamin D but not by calcium.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568009

Intermittent versus continuous administration of 1,25-dihydroxyvitamin D3 in experimental renal hyperparathyroidism.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568009

Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568009

1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568009

Stimulation by 1,25-dihydroxyvitamin D3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568009

Parathyroid growth and regression in experimental uremia

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568009

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568009

Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568009

Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568009

Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients. Durham Renal Osteodystrophy Study Group

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568009

A crossover comparison of intermittent oral and intravenous administration of calcitriol on the parathyroid hormone concentration in hemodialysis patients

20 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568009

1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells

20 October 2018

1 reference

12 December 2020

Characterization of endosteal osteoblastic cells isolated from mouse caudal vertebrae

1 reference

12 December 2020

Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure

1 reference

12 December 2020

Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis

1 reference

12 December 2020

Pharmacokinetics of calcitriol in continuous ambulatory and cycling peritoneal dialysis patients

1 reference

12 December 2020

Characterization of osteoblast-like cells from normal adult rat femoral trabecular bone

1 reference

12 December 2020

Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD

1 reference

12 December 2020

'Pulse oral' versus intravenous calcitriol therapy in chronic hemodialysis patients. A prospective and randomized study

1 reference

12 December 2020

Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient

1 reference

12 December 2020

Persistent hyperparathyroidism in renal allograft recipients: vitamin D receptor, calcium-sensing receptor, and apoptosis

1 reference

12 December 2020

Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism

1 reference

12 December 2020

Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients

1 reference

12 December 2020

Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients

1 reference

12 December 2020

Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol

1 reference

12 December 2020

Intravenous calcitriol can increase bone mass in hemodialysis patients with osteitis fibrosa

1 reference

12 December 2020

Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism

1 reference

12 December 2020

Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients

1 reference

12 December 2020

1,25-dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats

1 reference

12 December 2020

Identifiers

DOI

10.1093/NDT/GFN264

1 reference

17 August 2017

1 reference

17 August 2017

1 reference